Skip to menu Skip to content Skip to footer

2023

Conference Publication

The 1st Natural Killers of Brisbane Workshop

Souza-Fonseca-Guimaraes, Fernando (2023). The 1st Natural Killers of Brisbane Workshop. 1st Natural Killers of Brisbane Symposium, Brisbane, QLD, Australia, 24 July 2023.

The 1st Natural Killers of Brisbane Workshop

2023

Conference Publication

Weaponizing natural killer cells for solid cancer immunotherapy with mRNA approaches

Souza-Fonseca-Guimaraes, Fernando (2023). Weaponizing natural killer cells for solid cancer immunotherapy with mRNA approaches. QLD mRNA Symposium, Brisbane, QLD, Australia, 14 July 2023.

Weaponizing natural killer cells for solid cancer immunotherapy with mRNA approaches

2023

Conference Publication

Differential regulation of natural killer cells by tumor necrosis factor receptors 1 and 2

McCulloch, Timothy R., Rossi, Gustavo Rodrigues, Lam, Allie, Wong, Joshua, Kane, Lawrence P., Herold, Marco, Wells, Timothy and Souza-Fonseca-Guimaraes, Fernando (2023). Differential regulation of natural killer cells by tumor necrosis factor receptors 1 and 2. Immunology 2023™ Meeting, Washington, DC United States, 11-15 May 2023. Rockville, MD United States: American Association of Immunologists. doi: 10.4049/jimmunol.210.supp.72.28

Differential regulation of natural killer cells by tumor necrosis factor receptors 1 and 2

2023

Conference Publication

TIGIT limits anti-bacterial immunity and is a potential target for immunotherapy

Souza-Fonseca-Guimaraes, Fernando, Rossi, Gustavo Rodrigues, Wells, Timothy and McCulloch, Timothy Ryan (2023). TIGIT limits anti-bacterial immunity and is a potential target for immunotherapy. IMMUNOLOGY2023™ Meeting, Washington, DC, United States, 11 - 15 May 2023. Rockville, MD, United States: The American Association of Immunologists. doi: 10.4049/jimmunol.210.supp.64.14

TIGIT limits anti-bacterial immunity and is a potential target for immunotherapy

2023

Conference Publication

Enhancing natural killer cell therapies of paediatric sarcomas

Souza-Fonseca-Guimaraes, Fernando (2023). Enhancing natural killer cell therapies of paediatric sarcomas. QLD Paediatric Immunotherapy Conference, Brisbane, QLD, Australia, 29 April 2023.

Enhancing natural killer cell therapies of paediatric sarcomas

2023

Conference Publication

Checkpoint inhibitors in inflammatory diseases

Souza-Fonseca-Guimaraes, Fernando (2023). Checkpoint inhibitors in inflammatory diseases. Asia-Pacific Vaccine and Immunotherapy Congress, Brisbane, Qld, Australia, 26-28 April 2023.

Checkpoint inhibitors in inflammatory diseases

2023

Conference Publication

Experiences with the MRFF EMCR Stream 3

Souza-Fonseca-Guimaraes, Fernando (2023). Experiences with the MRFF EMCR Stream 3. UQ MRFF Research Development Event, Brisbane, QLD, Australia, 17 April 2023.

Experiences with the MRFF EMCR Stream 3

2023

Conference Publication

Weaponizing natural killer cells for cancer immunotherapy

Souza-Fonseca-Guimaraes, Fernando (2023). Weaponizing natural killer cells for cancer immunotherapy. VII Workshop LIM/31 HC-FMUSP of the University of Sao Paulo, Virtual, 1 April 2023.

Weaponizing natural killer cells for cancer immunotherapy

2022

Conference Publication

New insights in immunomodulation during infectious diseases

Souza-Fonseca-Guimaraes, Fernando (2022). New insights in immunomodulation during infectious diseases. Australasian Society of Immunology - Annual Meeting, Melbourne, VIC, Australia, 28-30 November 2022.

New insights in immunomodulation during infectious diseases

2022

Conference Publication

Updates on enhancing Natural Killer cell targeting of paediatric sarcomas

Souza-Fonseca-Guimaraes, Fernando (2022). Updates on enhancing Natural Killer cell targeting of paediatric sarcomas. Brisbane Cancer Conference, Brisbane, Qld, Australia, 24-25 November 2022.

Updates on enhancing Natural Killer cell targeting of paediatric sarcomas

2022

Conference Publication

New insights in immunomodulation during infectious diseases

Souza-Fonseca-Guimaraes, Fernando (2022). New insights in immunomodulation during infectious diseases. 9th EMBL Australia Postgraduate Symposium, Melbourne, VIC, Australia, 10-11 November 2022.

New insights in immunomodulation during infectious diseases

2022

Conference Publication

Development of NK cell-based immunotherapy for sarcoma

Souza-Fonseca-Guimaraes, Fernando (2022). Development of NK cell-based immunotherapy for sarcoma. Australia and New Zealand Sarcoma Association, Melbourne, Vic, Australia, 9-10 November 2023.

Development of NK cell-based immunotherapy for sarcoma

2022

Conference Publication

Enhancing Natural Killer cell targeting of paediatric sarcoma

Souza-Fonseca-Guimaraes, Fernando (2022). Enhancing Natural Killer cell targeting of paediatric sarcoma. Australia and New Zealand Sarcoma Association - Annual Meeting, Sydney, NSW, Australia, 4-5 November 2022.

Enhancing Natural Killer cell targeting of paediatric sarcoma

2022

Conference Publication

Deep single-cell, proteogenomic insights from SARS-CoV-2 infected lung tissues

Kulasinghe, Arutha, Tan, Chin Wee, Liu, Ning, Monkman, James, Killingbeck, Emily, Kim, Youngmi, Pan, Liuliu, Blick, Tony, Bhuva, Dharmesh, Feher, Kristen, Leon, Michael, Gregory, Mark, Short, Kirsty, Guimaraes, Fernando, Rhodes, Michael, Belz, Gabrielle and Davis, Melissa (2022). Deep single-cell, proteogenomic insights from SARS-CoV-2 infected lung tissues. SITC 37th Annual Meeting (SITC 2022), Boston, MA USA, 8-12 November 2022. London, United Kingdom: BMJ Publishing Group. doi: 10.1136/jitc-2022-sitc2022.0923

Deep single-cell, proteogenomic insights from SARS-CoV-2 infected lung tissues

2022

Conference Publication

New insights in immunomodulation during cancer and infection

Souza-Fonseca-Guimaraes, Fernando (2022). New insights in immunomodulation during cancer and infection. Araucaria Symposium, Curitiba, PR, Brazil, 25 October 2022.

New insights in immunomodulation during cancer and infection

2022

Conference Publication

Natural killer insights into the tumour microenvironment and children's cancer immunotherapy

Souza-Fonseca-Guimaraes, Fernando (2022). Natural killer insights into the tumour microenvironment and children's cancer immunotherapy. Kids Cancer Alliance 2022 Cell therapies in paediatric oncology, Virtual, 19-20 October 2022.

Natural killer insights into the tumour microenvironment and children's cancer immunotherapy

2022

Conference Publication

Immunomodulation and checkpoint inhibition during cancer and infection

Souza-Fonseca-Guimaraes, Fernando (2022). Immunomodulation and checkpoint inhibition during cancer and infection. XLVI Congress of the Brazilian Society of Immunology - IMMUNO 2022, São Paulo, SP, Brazil, 20-24 September 2022.

Immunomodulation and checkpoint inhibition during cancer and infection

2022

Conference Publication

Awakening natural killer cells for cancer therapy: the cure can be inside us

Souza-Fonseca-Guimaraes, Fernando (2022). Awakening natural killer cells for cancer therapy: the cure can be inside us. UQDI Winter Course of Advanced Immunology, Brisbane, Qld, Australia, 20-22 July 2022.

Awakening natural killer cells for cancer therapy: the cure can be inside us

2022

Conference Publication

TGF-b and CIS inhibition synergistically enhance natural killer cell-based immunity

Souza-Fonseca-Guimaraes, Fernando (2022). TGF-b and CIS inhibition synergistically enhance natural killer cell-based immunity. American Association of Immunologists - Annual Meeting, Portland, OR, United States, 7-10 May 2022.

TGF-b and CIS inhibition synergistically enhance natural killer cell-based immunity

2022

Conference Publication

New insights into immunomodulation during infectious diseases

Souza-Fonseca-Guimaraes, Fernando (2022). New insights into immunomodulation during infectious diseases. Asia-Pacific Vaccine and Immunotherapy Congress, Salt Beach, NSW, Australia, 2-4 May 2022.

New insights into immunomodulation during infectious diseases